Literature DB >> 20123319

Impaired kidney function and atrial fibrillation in elderly subjects.

Rajat Deo1, Ronit Katz, Bryan Kestenbaum, Linda Fried, Mark J Sarnak, Bruce M Psaty, David S Siscovick, Michael G Shlipak.   

Abstract

BACKGROUND: Impaired kidney function is associated with increased risk for cardiovascular events. We evaluated whether kidney function is associated with atrial fibrillation (AF) risk in elderly persons. METHODS AND
RESULTS: Subjects were participants in the Cardiovascular Health Study (CHS), a population-based cohort of ambulatory elderly. Measures of kidney function were cystatin C and creatinine-based estimated glomerular filtration rate (eGFR). Among the 4663 participants, 342 (7%) had AF at baseline and 579 (13%) developed incident AF during follow-up (mean 7.4 years). In unadjusted analyses, cystatin C quartiles were strongly associated with prevalent AF with a nearly 3-fold odds in the highest quartile compared with the lowest (HR=1.19, 95% CI [0.80-1.76] in quartile 2; HR=2.00, 95% CI [1.38-2.88] in quartile 3; and HR=2.87, 95% CI [2.03-4.07] in quartile 4). This increased risk for prevalent AF remained significant after multivariate adjustment. The risk for incident AF increased across cystatin C quartiles in the unadjusted analysis (HR=1.37, 95% CI [1.07-1.75] in quartile 2; HR=1.43, 95% CI [1.11-1.84] in quartile 3; and HR=1.88, 95% CI [1.47-2.41] in quartile 4); however, after multivariate adjustment, these findings were no longer significant. An estimated GFR <60 mL.min.1.73m(2) was associated with prevalent and incident AF in unadjusted, but not multivariate analyses.
CONCLUSIONS: Impaired kidney function, as measured by cystatin C, is an independent marker of prevalent AF; however, neither cystatin C nor eGFR are predictors of incident AF.

Entities:  

Mesh:

Year:  2009        PMID: 20123319      PMCID: PMC2818049          DOI: 10.1016/j.cardfail.2009.07.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  37 in total

1.  Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys.

Authors:  P M Rautaharju; P J MacInnis; J W Warren; H K Wolf; P M Rykers; H P Calhoun
Journal:  Methods Inf Med       Date:  1990-09       Impact factor: 2.176

2.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

3.  Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs).

Authors:  S Novo; L Adamo; A Giamporcaro; G Forte; B Longo; V B Gallo; G Licata; A Strano
Journal:  Agents Actions Suppl       Date:  1987

Review 4.  Body fluid volume regulation in health and disease: a unifying hypothesis.

Authors:  R W Schrier
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

5.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

6.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

7.  Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload.

Authors:  I H Zucker; A J Gorman; K G Cornish; M Lang
Journal:  Cardiovasc Res       Date:  1985-07       Impact factor: 10.787

8.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

Authors:  C D Furberg; B M Psaty; T A Manolio; J M Gardin; V E Smith; P M Rautaharju
Journal:  Am J Cardiol       Date:  1994-08-01       Impact factor: 2.778

Review 9.  Evidence for increased cardiovascular disease risk in patients with chronic kidney disease.

Authors:  Josef Coresh; Brad Astor; Mark J Sarnak
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-01       Impact factor: 2.894

Review 10.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

View more
  15 in total

1.  Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Faye L Lopez; Kunihiro Matsushita; Laura R Loehr; Sunil K Agarwal; Lin Y Chen; Elsayed Z Soliman; Brad C Astor; Josef Coresh
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

2.  Relation of renal function to risk for incident atrial fibrillation in women.

Authors:  Roopinder K Sandhu; Tobias Kurth; David Conen; Nancy R Cook; Paul M Ridker; Christine M Albert
Journal:  Am J Cardiol       Date:  2011-11-17       Impact factor: 2.778

3.  Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation.

Authors:  Jouni Karppi; Sudhir Kurl; Timo Heikki Mäkikallio; Kimmo Ronkainen; Jari Antero Laukkanen
Journal:  Eur J Epidemiol       Date:  2012-12-13       Impact factor: 8.082

4.  Bidirectional Association Between Kidney Function and Atrial Fibrillation: A Population-Based Cohort Study.

Authors:  Anna C van der Burgh; Sven Geurts; M Arfan Ikram; Ewout J Hoorn; Maryam Kavousi; Layal Chaker
Journal:  J Am Heart Assoc       Date:  2022-05-17       Impact factor: 6.106

5.  Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.

Authors:  Linzi Li; Elizabeth Selvin; Pamela L Lutsey; Ron C Hoogeveen; Wesley T O'Neal; Elsayed Z Soliman; Lin Y Chen; Alvaro Alonso
Journal:  Am Heart J       Date:  2018-08-10       Impact factor: 4.749

6.  eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Authors:  Nisha Bansal; Leila R Zelnick; Alvaro Alonso; Emelia J Benjamin; Ian H de Boer; Rajat Deo; Ronit Katz; Bryan Kestenbaum; Jehu Mathew; Cassianne Robinson-Cohen; Mark J Sarnak; Michael G Shlipak; Nona Sotoodehnia; Bessie Young; Susan R Heckbert
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-10       Impact factor: 8.237

7.  Two-Week Burden of Arrhythmias across CKD Severity in a Large Community-Based Cohort: The ARIC Study.

Authors:  Esther D Kim; Elsayed Z Soliman; Josef Coresh; Kunihiro Matsushita; Lin Yee Chen
Journal:  J Am Soc Nephrol       Date:  2021-01-28       Impact factor: 10.121

8.  Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.

Authors:  Roopinder K Sandhu; David Conen; Usha B Tedrow; Kathryn C Fitzgerald; Aruna D Pradhan; Paul M Ridker; Robert J Glynn; Christine M Albert
Journal:  J Am Heart Assoc       Date:  2014-05-01       Impact factor: 5.501

9.  Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study.

Authors:  Richard L Amdur; Monica Mukherjee; Alan Go; Ian R Barrows; Ali Ramezani; Jun Shoji; Muredach P Reilly; Joseph Gnanaraj; Raj Deo; Sylvia Roas; Martin Keane; Steve Master; Valerie Teal; Elsayed Z Soliman; Peter Yang; Harold Feldman; John W Kusek; Cynthia M Tracy; Dominic S Raj
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

10.  Impact of Impaired Renal Function on the Incidence of Atrial Fibrillation following Radiofrequency Ablation of Cavotricuspid Isthmus-Dependent Atrial Flutter.

Authors:  Chang Hee Kwon; Jun Kim; Min Su Kim; Jae-Hyung Roh; Jin Hee Choi; Uk Jo; Woo Seok Lee; Yoo Ri Kim; Gi-Byoung Nam; Kee-Joon Choi; You-Ho Kim
Journal:  Korean Circ J       Date:  2015-11-25       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.